Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Thalamocortical brain activity and noninvasive stimulation in chronic and pressure pain

Official title: Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain - Phase II

Run by The University of Texas Health Science Center, Houston · NCT06968689 · Data updated 2026-11-12

This research tests whether noninvasive brain stimulation (tACS or tRNS), measured with EEG and fMRI during tonic pressure pain, can change thalamocortical activity and alter pressure pain ratings in people with pain.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedJune 1, 2025
Main results expectedDecember 31, 2027
Study endsFebruary 29, 2028
Registry record updatedMarch 2, 2026
Trial IDNCT06968689 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who can pass MRI and EEG screening, are fluent in English, and do not have major medical, neurological, or psychiatric conditions or contraindications such as metal implants, pregnancy, or recent head trauma are ideal candidates.

Probably not a fit

People who are pregnant, have MRI contraindications (e.g., pacemaker, metal implants, severe claustrophobia), active substance abuse, severe psychiatric or neurological disorders, or who cannot tolerate lying still in a scanner are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The protocol combines EEG and fMRI to measure thalamocortical connectivity and alpha-band activity while participants experience tonic pressure pain. Participants receive sessions of transcranial alternating current stimulation (tACS), transcranial random noise stimulation (tRNS), and sham stimulation while subjective pressure pain ratings are recorded. Neurophysiological signals across conditions will be compared to determine how each stimulation type modifies thalamocortical patterns and alpha activity. Results aim to link specific brain rhythms to pressure pain and the immediate neuromodulatory effects of the stimulation techniques.

Why it matters

Potential benefit: If successful, this work could identify brain rhythms to target with noninvasive stimulation and point toward new methods to reduce pressure-related pain.

How similar studies have gone: Previous small studies using tACS or tRNS to modulate brain rhythms and pain have produced mixed but promising results, with larger confirmatory trials still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Meet the MRI / EEG screening criteria
* Fluent in English

Exclusion Criteria:

* Current or history of major medical, neurological, or psychiatric illness based on self-report
* History of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome (for example: asthma or claustrophobia)
* History of head trauma
* Pregnant or lactating
* Presence of any contraindications to MRI scanning (for example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner)
* Conditions making study participation difficult (e.g., paralysis, psychoses, or other severe psychological problems as per the judgment of a study investigator during Session 1)
* Active substance abuse disorders (based on subject self-report)

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Wen Li, PhD — The University of Texas Health Science Center, Houston
  • Study coordinator: Wen Li, PhD
  • Email: Wen.Li.1@uth.tmc.edu
  • Phone: (713) 486-2700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.